Cardiovascular Risk After Sepsis: Understanding the Role of Statin Indications and the Impact of Clinical Inertia on Prescribing Patterns.
Vedant A GuptaTalal S AlnabelsiSandipan ShringiSteve W LeungVincent L SorrellPublished in: Journal of cardiovascular pharmacology and therapeutics (2020)
There is a high risk of MACE after sepsis especially among those in statin indicated groups with significant clinical inertia in prescribing practices.